| A review of stimuli-responsive nanocarriers for drug and gene delivery S Ganta, H Devalapally, A Shahiwala, M Amiji Journal of controlled release 126 (3), 187-204, 2008 | 2554 | 2008 |
| Chitosan-based gastrointestinal delivery systems R Hejazi, M Amiji Journal of controlled release 89 (2), 151-165, 2003 | 1204 | 2003 |
| Poly (ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery LE Van Vlerken, TK Vyas, MM Amiji Pharmaceutical research 24, 1405-1414, 2007 | 810 | 2007 |
| Exosome mediated communication within the tumor microenvironment L Milane, A Singh, G Mattheolabakis, M Suresh, MM Amiji Journal of Controlled Release 219, 278-294, 2015 | 755 | 2015 |
| Biodegradable poly (ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen JS Chawla, MM Amiji International journal of pharmaceutics 249 (1-2), 127-138, 2002 | 644 | 2002 |
| Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells S Ganta, M Amiji Molecular pharmaceutics 6 (3), 928-939, 2009 | 601 | 2009 |
| Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine G Mattheolabakis, L Milane, A Singh, MM Amiji Journal of drug targeting 23 (7-8), 605-618, 2015 | 584 | 2015 |
| Preparation and characterization of freeze-dried chitosan-poly (ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach VR Patel, MM Amiji Pharmaceutical research 13, 588-593, 1996 | 549 | 1996 |
| Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers M Amiji, K Park Biomaterials 13 (10), 682-692, 1992 | 514 | 1992 |
| Multi-functional nanocarriers to overcome tumor drug resistance LS Jabr-Milane, LE van Vlerken, S Yadav, MM Amiji Cancer treatment reviews 34 (7), 592-602, 2008 | 508 | 2008 |
| Poly (ethylene oxide)-modified poly (ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer DB Shenoy, MM Amiji International journal of pharmaceutics 293 (1-2), 261-270, 2005 | 498 | 2005 |
| Multi-functional polymeric nanoparticles for tumour-targeted drug delivery LE Van Vlerken, MM Amiji Expert opinion on drug delivery 3 (2), 205-216, 2006 | 493 | 2006 |
| Surface modification of polymeric biomaterials with poly (ethylene oxide), albumin, and heparin for reduced thrombogenicity M Amiji, K Park Journal of Biomaterials Science, Polymer Edition 4 (3), 217-234, 1993 | 472 | 1993 |
| Enzyme immobilization in novel alginate–chitosan core-shell microcapsules E Taqieddin, M Amiji Biomaterials 25 (10), 1937-1945, 2004 | 428 | 2004 |
| Technologies and standardization in research on extracellular vesicles S Gandham, X Su, J Wood, AL Nocera, SC Alli, L Milane, A Zimmerman, ... Trends in biotechnology 38 (10), 1066-1098, 2020 | 415 | 2020 |
| pH‐responsive polymer microspheres: Rapid release of encapsulated material within the range of intracellular pH DM Lynn, MM Amiji, R Langer Angewandte Chemie 113 (9), 1757-1760, 2001 | 399 | 2001 |
| Long-circulating poly (ethylene glycol)-modified gelatin nanoparticles for intracellular delivery G Kaul, M Amiji Pharmaceutical research 19, 1061-1067, 2002 | 393 | 2002 |
| Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices E Gultepe, D Nagesha, S Sridhar, M Amiji Advanced drug delivery reviews 62 (3), 305-315, 2010 | 381 | 2010 |
| Role of integrated cancer nanomedicine in overcoming drug resistance AK Iyer, A Singh, S Ganta, MM Amiji Advanced drug delivery reviews 65 (13-14), 1784-1802, 2013 | 380 | 2013 |
| Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors S Ganesh, AK Iyer, DV Morrissey, MM Amiji Biomaterials 34 (13), 3489-3502, 2013 | 380 | 2013 |
Srinivas GantaSynta Pharmaceuticals在 syntapharma.com 的電子郵件地址已通過驗證
